Group items tagged

Using Precision Medicine to Address Health Disparities is organized by eMedEvents Corporation. Efforts to solve, and overcome health disparities have yielded modest changes.

The latest findings from the National Cancer Patient Experience Survey 2022 by QualityWatch, a joint programme with the Nuffield Trust and the Health Foundation shed light on concerning disparities faced by ethnic minority communities in the UK healthcare system. Despite strides in cancer care, the survey highlights persistent challenges in easy and equitable access to timely diagnosis and quality communication, particularly for individuals from Mixed, Black, or Asian backgrounds. Key insights from the survey underscored that individuals from ethnic minority groups often require a higher number of interactions with healthcare professionals before receiving a cancer diagnosis. Notably, one in three people from Mixed, Black, or Asian ethnicities needed three or more visits to a GP practice, compared to the average of one in five across the population. These delays in diagnosis can have significant implications for treatment outcomes and overall patient experience. Moreover, the survey revealed concerning trends regarding the quality of communication following a cancer diagnosis among ethnic minority patients.

In a significant move to address health disparities and enhance clinical research, community pharmacies across several regions are set to become central players in the Genes and Health study. Led by Queen Mary University of London and funded by the Wellcome Trust, this national initiative aims to improve health outcomes within British-Bangladeshi and British-Pakistani communities. Professor Mahendra Patel, Director of the Centre for Research Equity at the University of Oxford, highlighted the importance of this approach. "By engaging the broader pharmacy workforce, including technicians, we aim to establish a research-ready infrastructure within community pharmacies," Patel told Pharmacy Business. He shared that the initiative marks a transformative step in integrating pharmacies into the clinical research landscape. The Thames Valley and South Midlands Clinical Research Network (CRN) is managing a pioneering pilot program for this study, which will initially focus on pharmacies in Banbury, Oxford City, Reading, Slough, High Wycombe, and Aylesbury.

Health Disparities in Trans youth is organized by eMedEvents Corporation from Jul 05, 2022 - Jul 05, 2023. Identify and define the LGBTQIA vocabulary.

The 2011 report presents expanded analyses of care received by older Americans. It also addresses six priority areas for quality improvement, as identified in the National Strategy for Quality Improvement in Health Care report and presents novel strategies for improving quality and reducing disparities from AHRQ's Health Care Innovations Exchange.

Despite being the most common genetic disorder in the UK, sickle cell disease (SCD) remains significantly underfunded and underserved compared to other genetic disorders, according to a new report published by the PDA BAME (Black, Asian and Minority Ethnic) Pharmacists' Network. The report also reveals that the disease is poorly understood within the healthcare system, including amongst pharmacists, pharmacy students, and foundation pharmacists in the UK. It emphasises the urgent need for increased awareness, funding, and improved healthcare access for SCD amongst these healthcare professionals. "A lack of education about SCD within the wider healthcare community, including pharmacy, greatly contributes to disparities in care. "Though the importance of SCD education for pharmacists and allied healthcare professionals is acknowledged, it remains unclear whether this topic is adequately addressed within the MPharm curriculum," the report said. The report further noted that in the absence of explicit guidance from the General Pharmaceutical Council (GPhC) or the Pharmaceutical Society of Northern Ireland (PSNI) and without more comprehensive education surrounding SCD embedded within the pharmacy curriculum, pharmacists and future pharmacists may remain "ill-prepared to manage patients with this complex condition." As per the report, sickle cell disease is the most prevalent genetic disorder globally, impacting millions, including around 17,000 people in England.

The recent announcement that Royal Mail will be partnering with distance selling pharmacy (DSP) giant pharmacy2U highlights how standards of regulatory enforcement are being ignored to accommodate the DSP model. The brunt of these double standards hinges around the levelling down of temperature enforcement standards by the Medicines and Healthcare products Regulatory Agency (MHRA) which demands mapping must be audited from the point of dispensing to the patient. The MHRA has a well recognised duty to ensure medicines reach patients in a safe condition. The current anomaly appears to turn a blind eye to this step in the supply chain at the point the wholesaler releases goods to the pharmacy hub. Equally the training on delivering medicines safely and effectively direct to patients should apply fully to all hubs including DSPs. Why is it that DSPs are being treated differently to bricks and mortar pharmacies? It's essentially the same patients receiving the same medicines from the same wholesalers. A further regulatory disparity exists around how parcels must be "tracked and signed for" to be reasonably certain medicines are delivered into the hand of the intended recipient, as per existing regulations. Clearly an untracked, unsigned package cannot be guaranteed to finish in the hands of the intended recipient. There is a very real possibility that such omission could lead to community pharmacy closures which will, in turn, lead to unemployment and a reduction in the care services. At a time when integrated care systems have just gone live, the removal of vital support services leading to further inequalities is the wrong message for both providers and patients alike.

Pharmacists from BAME backgrounds still face higher levels of discrimination, harassment, bullying, and career obstacles compared to their white counterparts, the Pharmacy Workforce Race Equality Standard (PWRES) report has revealed. Published by NHSE England, this report underscores the persistent presence of inequality, emphasising the crucial need for all stakeholders in the pharmacy sector to prioritise addressing these issues. The PWRES report indicates that pharmacy team members of Black ethnic backgrounds are less likely to perceive equal opportunities for career advancement or promotion within their trust. Additionally, female pharmacy team members from BAME backgrounds report higher incidents of personal discrimination in the workplace. The report also highlights an overrepresentation of pharmacy technicians from BAME backgrounds in lower-paid roles. "It is shocking and unacceptable to see that across all indicators the BME staff experience is worse than their white counterparts," said Tase Oputu, Chair of RPS in England.

The NHS is facing a range of long term challenges which needs to be countered with prevention, enhance personalised care and sustainable performance, health and social care secretary Sajid Javid said on Tuesday (March 8). In his speech on healthcare reform at the Royal College of Physicians in London, he said: "We face some long-term challenges: how to keep the NHS focused on delivery while futureproofing it for changing demographics and disease; how to meet rising patient expectations and address the injustices of widespread disparities; and how to deal with an unsustainable financial trajectory while backing the brilliant people who work in health and care." Javid emphasised on three key points for healthcare reform - prevention, personalisation and performance. He said, prevention is not just about building a 'national hospital service' but a true 'National Health Service'.

The Royal Pharmaceutical Society (RPS) presented key evidence to the UK COVID-19 Inquiry on 10 September, underscoring the vital role of pharmacists and pharmacy teams during the pandemic. Deirdre Domingo, legal representative for the RPS, delivered the statement during the Module 3 public hearings, which focus on the impact of COVID-19 on healthcare systems across the UK. As the professional body representing pharmacists and pharmaceutical scientists in Great Britain, the RPS urged the Inquiry to consider several critical issues: Recognition of pharmacists as key workers The RPS highlighted the crucial role pharmacy teams played in ensuring continued access to essential medicines and their integral involvement in the roll-out of COVID-19 and flu vaccinations. However, the Society also raised concerns over significant failures and challenges, such as inadequate safety measures to protect pharmacists at work, confusing national guidance, increased hostility towards healthcare professionals, and a disparity in the treatment of community pharmacy compared to NHS staff.

In preparation for World Pharmacists Day on September 25, Pharmacy Business conducted a social media poll to explore how pharmacists can improve global health outcomes. More than 64 per cent of respondents indicated that pharmacists should prioritize promoting preventive care. Other suggestions included advancing research and development (9 per cent), increasing interdisciplinary collaboration (14 per cent), and addressing health disparities (14 per cent). This year's theme for World Pharmacists Day is "Pharmacists: Meeting Global Health Needs." The International Pharmaceutical Federation (FIP) emphasises that pharmacists are integral members of healthcare systems, playing a crucial role in meeting health needs in various ways daily.

The UK recorded an estimated 66,730 serious antibiotic-resistant infections in 2023, surpassing the pre-pandemic figure of 62,314 in 2019, a new report from the UK Health Security Agency (UKHSA) has revealed. Antibiotic resistant bacteria are less likely to respond to treatment and can cause serious complications, including bloodstream infections, sepsis and hospitalisation. The national surveillance data published by the UKHSA showed that E. coli - a common cause of urinary tract infections, diarrhoea, vomiting and fever, accounted for 65 per cent of antibiotic-resistant bloodstream infections in the last five years. The English Surveillance of Antibiotic Prescribing and Utilisation Report (ESPAUR) highlighted a stark disparity in infection rates. People in the most deprived communities were 42.6 per cent more likely to experience an antibiotic-resistant infection in 2023 compared to those in the least deprived areas, a significant rise from 29.4 per cent in 2019. Overall, resistant infection rates in the most deprived areas of England increased by 9.5 per cent between 2019 and 2023.

The government has received thousands of ideas to fix the NHS as the biggest ever conversation about the future of the health service reached the Midlands last week. More than 100 people from across the Midlands participated in the public debate in Wigston in Leicestershire on Saturday (23 November), sharing their experiences, views and suggestions for delivering an NHS fit for the future. Public health minister Andrew Gwynne and NHS England's national director for urgent and emergency care Sarah-Jane Marsh attended the debate, inviting attendees' opinions on NHS reform and how the government's 10 Year Health Plan can help tackle disparities in the region. Addressing the event, Gwynne said: "We can't change the NHS and make it better without you." "When we say that the NHS is broken but not beaten, it's not beaten because the staff are incredible, it is because the NHS is not where we need it to be."

A new study published in BMJ Open journal has revealed a significant decline in the number of general practices in England over the past decade, alongside shifts in workforce dynamics and organisational structures. Conducted by researchers from University College London (UCL) and the London School of Hygiene and Tropical Medicine (LSHTM), the study analysed data from NHS England, the Office for Health Improvement and Disparities, and the Care Quality Commission (CQC). They found that, between April 2013 and April 2023, the total number of general practices fell by 20 per cent, dropping from 8,044 to 6,419-an average loss of 178 practices per year. The decline coincided with an 11 per cent increase in the total population registered with a GP practice, which saw average practice list sizes swell by 40 per cent from 6,967 to 9,724 patients. Additionally, the number of unique practice postcodes decreased from 7163 to 5849, representing the loss of 18 per cent practice locations over this period.

A recent report by the Company Chemists' Association (CCA) has revealed a significant disparity in patient engagement with the Pharmacy First service across the UK. In response, Santosh Sahu, Founder and CEO at Charac, has emphasised the need for technological reform to address "the interoperability gap between pharmacists and GPs". Sahu identified the lack of GP referrals for Pharmacy First consultations as a key issue, attributing it to inadequate IT infrastructure. He urged the sector to "implement technological reforms to enhance interoperability between pharmacists and GPs, enabling them to share patient records, identify care pathways, and address health needs more effectively".

The University of Oxford's Centre for Research Equity (CfRE) has entered into a historic partnership with the Health and Social Care Research and Development (HSC R&D) Division in Northern Ireland to advance health equity across the region and ensure everyone benefits from healthcare advancements. Unveiled during an event at Parliament Buildings in Stormont Estate on Wednesday, this groundbreaking partnership makes Northern Ireland the first UK region to partner with CfRE. Supported by the Department of Health Northern Ireland and key health and social care agencies, the partnership aims to improve health outcomes and reduce disparities through collaborative research. Northern Ireland's Health Minister, Mike Nesbitt, highlighted that this new partnership represents "a significant step forward in efforts to address health inequalities" in the region. "By bringing together leading experts and resources from across sectors, we can work towards conducting research that truly benefits all of our communities," he said.

Since its launch on January 31st, the Pharmacy First service by the Company Chemists Association (CCA) has achieved a significant milestone, completing over 200,000 consultations to date. This milestone underscores the service's vital role in providing same-day NHS care through community pharmacies across England. Recent analysis by the CCA has revealed a pressing need to bolster GP referrals, with disparities observed between different Integrated Care System (ICS) areas, resulting in what's described as a 'postcode lottery' for patients. CCA Chief Executive, Malcolm Harrison, emphasised the importance of sustained funding for Pharmacy First beyond 2025, ensuring its availability for patients, community pharmacies, and the wider NHS.

A recent analysis conducted by the Company Chemists' Association (CCA) has revealed stark disparities in patient engagement with the Pharmacy First service across the country, likening the pattern to a 'patchwork quilt'. It indicated that patients in the highest-performing Integrated Care System (ICS) received seven times more Pharmacy First consultations than those in the lowest-performing regions. As of April 21, more than 3,000 CCA member pharmacies had delivered 126,484 Pharmacy First consultations since the programme's launch. However, the analysis found significant regional variations, with nearly 13,000 consultations completed in the North East and North Cumbria ICS, while only 948 were completed in Gloucestershire ICS. The CCA calculated that if every ICS had as many consultations as the highest-performing ICS, there would have been an additional 600,000 Pharmacy First consultations nationwide.

The UK incurs substantial healthcare costs for managing dental caries (tooth decay), with per-person expenses estimated at £18,000, a new study has revealed. This figure is notably higher than those reported in countries such as Brazil, France, Germany, Indonesia, and Italy. Published in BMC Public Health and commissioned by the European Federation of Periodontology (EFP), the study also found that the economic impact of tooth decay is disproportionately higher in the most deprived groups. Researchers, including Professors Moritz Kebschull and Iain Chapple from the University of Birmingham's School of Dentistry, suggested that targeted preventative measures could help reduce this financial burden dramatically. "Our study highlights the critical need for early and sustained preventive measures to address the economic and health disparities associated with dental caries," said Professor Chapple. "By focusing on the most vulnerable populations, we can achieve substantial cost savings and improve overall oral health outcomes."

The Royal Pharmaceutical Society (RPS) has revealed the "differential attainment" gap among Black pharmacy students and Foundation trainees. Research conducted by pharmacy education has revealed unique challenges leading to lower attainment in the registration assessment and an undergraduate awards gap compared to white students. The organisation plans to work with new groups including BPSA, GPhC, NHS England, Pharmacy Schools Council and representatives from Schools of Pharmacy, to achieve a fair and equitable education and training experience for the students. They plan to reach out to student representative organisations to secure their participation in a quarterly meeting of the group. Differential attainment is the unexplained variation between groups who share a protected characteristic, for example, ethnicity, gender and disability.